Learn about advanced treatments for breast cancer with liver and lung metastasis in Germany, including Dendritic Cell Therapy, TACE, and TACP, available for international patients with full coordination and visa support (if needed)

Breast Cancer with Liver and Lung Metastasis

For women diagnosed with breast cancer that has spread to the liver or lungs, precision-based care and innovative therapies can significantly improve disease management and comfort. Metastatic breast cancer, though advanced, remains treatable, and modern medicine now offers targeted ways to control its spread and improve quality of life. In Germany, oncologists are globally recognized for their commitment to research-driven cancer care, safety, and personalized treatment planning. German healthcare institutions provide therapies that combine immunotherapy, interventional radiology, and targeted chemotherapy, designed according to each patient’s individual condition.

In Germany, TIG (Treatment in Germany) provides seamless coordination and complete logistic arrangements for patients, including travel, lodging, and medical visa for international patients (if required). This approach ensures that patients are guided through every stage of care, from diagnostics to recovery, in a stress-free and transparent manner.

Understanding Breast Cancer with Liver and Lung Metastasis

When breast cancer metastasizes to distant organs such as the liver and lungs, cancer cells have moved through the bloodstream or lymphatic system and established secondary tumors. These metastases may cause fatigue, pain, or breathing difficulties, but with proper management, many patients can continue living fulfilling lives.

In Germany, specialists take a systematic and scientific approach to diagnosis and treatment. Detailed imaging such as MRI, CT, and PET-CT scans help identify the exact tumor location and spread. Based on these diagnostics, oncologists, radiologists, and immunotherapy experts design treatment strategies that are precise and patient-specific. Every therapy in German healthcare centers is conducted under strict regulatory standards, ensuring safety, monitoring, and adherence to international best practices. This commitment to medical excellence is one of the reasons why thousands of international patients choose treatment in Germany every year.

Why Germany Is a Global Leader in Metastatic Breast Cancer treatment

Germany stands at the forefront of metastatic breast cancer treatment, combining innovation, research, and personalized medicine to deliver exceptional patient outcomes. The country’s healthcare system emphasizes precision-based care supported by advanced diagnostics, cutting-edge technology, and strict safety regulations. In Germany, each patient’s treatment plan is designed through close collaboration between the best oncologists, radiologists, and immunotherapy experts, ensuring that therapies are both targeted and safe. International patients benefit from affordable treatment in Germany, transparent pricing, and ongoing monitoring throughout their care.

Treatment Options for Breast Cancer with Liver and Lung Metastasis in Germany

Doctors in Germany use a combination of innovative and targeted therapies to treat breast cancer with liver and lung metastasis, based on tumor type, extent, and response to previous treatments. The most advanced options include innovative dendritic Cell Therapy, Transarterial Chemoembolization (TACE), and Transarterial Chemoperfusion (TACP) ,each designed to achieve maximum efficacy with minimal side effects.

Dendritic Cell Therapy for breast cancer with liver and lung metastasis

Dendritic Cell Therapy (DCT) is one of Germany’s most innovative immunotherapy treatments, enhancing the body’s ability to recognize and destroy cancer cells. For patients with breast cancer metastases to the liver or lungs, this therapy offers a way to strengthen the immune system against hidden or resistant tumor cells. The process involves drawing a small sample of blood, isolating immune cells, and processing them in an EU-GMP-certified laboratory. These dendritic cells are then “trained” with tumor-specific antigens before being reintroduced into the patient’s body to activate an immune response.

The therapy is led by Prof. Gansauge in Berg, a pioneer in personalized cancer vaccines and immunological oncology. The cost of Dendritic Cell Therapy in Germany is approximately €24,000, covering laboratory cell preparation, activation, and administration. Results depend on tumor size, spread, and individual immune response, but the therapy is valued for its safety, precision, and compatibility with other cancer treatments.

Transarterial Chemoembolization (TACE) for breast cancer with liver and lung metastasis

TACE treatment in Germany is a minimally invasive procedure used primarily for liver metastases. It delivers chemotherapy directly into the arteries supplying the tumor, followed by embolic particles that block the blood flow. This dual action traps chemotherapy within the tumor, increasing its local effectiveness and reducing exposure to healthy tissue.

The procedure is performed by Prof. Vogl at Frankfurt University Hospital, an internationally acclaimed interventional radiologist. The cost of TACE in Germany is around €8,000–€9,000 per session, depending on tumor complexity and the number of treated areas.

Outcomes depend on tumor location, vascular anatomy, and disease progression. Each session is performed under advanced imaging and monitored according to strict safety protocols, ensuring optimal precision and minimal side effects.

Transarterial Chemoperfusion (TACP) for breast cancer with liver and lung metastasis

TACP therapy is another targeted treatment for patients with breast cancer metastases in the liver and lungs. Unlike TACE, TACP focuses solely on infusing chemotherapy directly into the arteries feeding the tumor without embolization, maximizing local drug concentration while minimizing systemic exposure. Prof. Vogl leads this treatment in Frankfurt, applying decades of research and clinical experience in interventional oncology. The cost of TACP in Germany is approximately €8,000 to €9,000 per session.

As with other treatments, results depend on tumor size, disease behavior, and patient health. All therapies are performed in compliance with German regulatory standards and include thorough monitoring to ensure patient safety and therapeutic accuracy.

How TIG Supports International Patients

International patients begin their journey by contacting Treatment in Germany (TIG) at www.treatmentingermany.de . TIG provides comprehensive support, managing consultations, travel, accommodations, follow-up care, and medical visa for international patients (if required), ensuring a smooth experience.

The Importance of Early Evaluation

Early evaluation and accurate diagnostics play a vital role in controlling breast cancer with liver and lung metastasis. By identifying changes in disease progression at an early stage, doctors can adjust treatments before complications arise. Best German oncologists emphasize regular monitoring, including imaging and laboratory assessments, to track response to therapy. Outcomes depend on tumor size, disease extent, and individual health, and no treatment can guarantee a cure. However, with timely intervention, many patients experience improved control and stability.

Cost Transparency and Accessibility in Germany

Germany’s healthcare system combines medical excellence with cost transparency. The overall cost of treatment depends on therapy type, duration, and individual medical needs. Nevertheless, Germany remains cost-effective compared to other countries due to efficient systems, short hospital stays, and evidence-based protocols.

In German health centers, the emphasis is on precise diagnostics, continuous monitoring, and evidence-based decisions. Specialists take into account factors such as tumor size, disease behavior, and overall health status. With access to the latest medical technology in Germany for international patients, care is designed to be both preventive and proactive, ensuring that no detail is overlooked.

🌍Why Patients Worldwide Prefer Our Medical Services in Germany – Key Benefits Explained:

Frequently Asked Questions (FAQs)

Can breast cancer with liver and lung metastasis be treated in Germany?
Yes, Germany offers advanced therapies such as Dendritic Cell Therapy, TACE, and TACP, tailored according to each patient’s case.

Who are the key specialists for these therapies?
Prof. Dr. Frank Gansauge for Dendritic Cell Therapy, while Prof. Dr. Thomas J. Vogl for TACE and TACP procedures.

What is the cost of treatment in Germany?
Dendritic Cell Therapy costs approximately €24,000, and TACE or TACP ranges from €8,000 to €9,000 per session, depending on complexity.

Are these therapies safe for international patients?
Yes, all treatments are performed under EU-regulated standards, ensuring safety, monitoring, and regulatory compliance.

Can Dendritic Cell Therapy be combined with TACE or TACP?
Yes, in selected cases, Dendritic Cell Therapy can complement TACE or TACP to enhance immune activation and local tumor control.

Is Dendritic Cell Therapy approved in Germany?
Yes, it is performed under EU-GMP laboratory certification, ensuring high-quality and safe preparation of immune cells.

How long does treatment take in Germany?
Treatment duration varies depending on stage, size and complexity of tumor.

What side effects can occur during treatment?
Side effects are generally mild and may include fatigue or local reactions, all managed under professional medical supervision.

What diagnostic tests are used before starting therapy?
MRI, CT, and PET-CT scans are used to map tumor activity and plan treatment precisely.

How can international patients access treatment in Germany?

Treatment in Germany (TIG) ensures seamless coordination and complete logistic arrangements for international patients, including travel, lodging, and medical visa for international patients at www.treatmentingermany.de.

Why do international patients choose Germany for cancer care?
Because of research, innovation, affordability, and personalized patient care backed by world-leading specialists and best oncologists.

Who is the best cancer specialist for breast cancer with liver and lung metastasis in Germany?
Germany has many highly experienced oncologists and specialized cancer centers known for advanced diagnostics and personalized treatment approaches. The “best” cancer specialist depends on the specific cancer type and treatment needs. Some of the most recognized cancer experts include professors working at leading hospitals such as Charité University Hospital (Berlin), University Hospital Heidelberg, University Hospital Munich (LMU), and Frankfurt University Hospital.

Why Germany Leads in Cancer Innovation

Germany continues to pioneer oncology research, integrating precision medicine with advanced diagnostics and safe treatment methods. From Dendritic Cell Therapy to TACE and TACP, the country offers scientifically validated, patient-centered solutions delivered by globally recognized specialists.

Why Choose Treatment in Germany

Access to EU-certified Dendritic Cell Therapy, TACE, and TACP

Personalized plans for breast cancer with liver and lung metastasis

Comprehensive support via TIG (Treatment in Germany) and medical visa for international patients (if required).

Continuous patient monitoring and compassionate care